Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3

National Institute on Drug Abuse (NIDA)

Overview

The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Conditions

Interventions

LofexidineDRUG

Eligibility

Sex: ALLMin age: 21 YearsMax age: 59 Years

Medical Language ↔ Plain English

Please contact site for information.

Locations (1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.